Optimised transient- and scalable production systems for high quality, high titre AAV production.
Transient AAV production
Our reconfigured Rep-Cap plasmid, modified Ad5 helper and GMP banked clonal suspension HEK293 cell line offer improved AAV quality and yield.
TESSA™: scalable AAV production
Our proprietary Tet-enabled self silencing adenoviral (TESSA™) AAV manufacturing system delivers high-yield, high quality AAV in a scalable, contaminant, chemical and transfection free process.
From our experts to yours, our scientists offer ongoing comprehensive technical support so you can have complete confidence in the performance of our technologies once transferred to your own facilities.
AAV at the edge of impossible
OXGENE's transient AAV production system and process development support facilitates high quality, high-titre AAV production. Our revolutionary new TESSA™ scalable system offers a plasmid free alternative for large scale clinical manufacture.